Editorial role

Expertise

Molecular genomics

Selected publications

  1. Rafeeq MM, Alghamdi S, Qasem AH, Almehmadi SJ, Al-Moraya IS, Alkathiri A, Almotairi RM, Alam Q (2023). Curcumin as a potent inhibitor molecule for mixed lineage kinase: a molecular docking and in vitro study for potential cancer treatment Curcumin as a potent inhibitor molecule for mixed lineage kinase: a molecular docking and in vitro study for potential. Bioscience Research; 20(2): 549-556.
  2. 2. Alzahrani A, Kamal MA, Akber AH, Asiri AA, Shafei MI, Ghawi MH, Alotaibi HM, Alam Q (2023). Molecular docking analysis of EGFRinhibitors for breast cancer management. Bioinformation; 19(6): 707-712.
  3. 3. Umair M, Afsar T, Khan H, Ali Z, Zehri Z, Zaman G, Hussain A, Zeb S, Alam Q; Razak S (2023). Variant in LRR Domain of SLITRK2 Underlying X-linked Neurodevelopmental Disorders. Journal of Gene Medicine (Submitted). I.F. 3.5
  4. 4. Alghamdi S, Baeissa HM, Kamal MA, Rafeeq MM, Al Zahrani A, Maslum AA, Hakeem IJ, Alzragi RS, Alam Q (2023). Unveiling the multitargeted potency of Sodium Danshensu against Cervical Cancer: A Multitargeted Docking-based, Structural Fingerprinting and Molecular Dynamics Simulation Study. Journal of Biomolecular Structure and Dynamics. doi: 10.1080/07391102.2023.2248260I.F. 4.5
  5. 5. Umair Muhamma; Afsar, Tayyaba; Khan, Hammal; Ali, Zain; Zehri, Zamrud; Zaman,
  6. Gohar; Hussain, Amir; Zeb, Shah; Alam, Qamre; Razak, Suhail (2023). Variant in LRR
  7. Domain of SLITRK2 Underlying X-linked Neurodevelopmental Disorder. Journal of Gene
  8. Medicine. (Under Review) I.F. 3.5

Read more of it

Subscribe to one journal or build your own list of several. One invoice, one payment, access for a full year.

Subscribe to journals →

Publish your article

Peer-reviewed journals across every subject, with open access options. Send your manuscript to the right editor today.

Publish with us → Calculate your APC
Support